BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37592286)

  • 1. Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening.
    Woks NIE; Anwi MM; Kefiye TB; Sama DJ; Phuti A
    Int J Equity Health; 2023 Aug; 22(1):156. PubMed ID: 37592286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
    Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
    Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review.
    Petersen Z; Jaca A; Ginindza TG; Maseko G; Takatshana S; Ndlovu P; Zondi N; Zungu N; Varghese C; Hunting G; Parham G; Simelela P; Moyo S
    BMC Womens Health; 2022 Dec; 22(1):486. PubMed ID: 36461001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature.
    Greenley R; Bell S; Rigby S; Legood R; Kirkby V; McKee M;
    Front Public Health; 2023; 11():1144674. PubMed ID: 37304105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.
    Marques P; Nunes M; Antunes MDL; Heleno B; Dias S
    Int J Equity Health; 2020 Sep; 19(1):160. PubMed ID: 32917224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening programs for female sex workers: a scoping review.
    Vimpere L; Sami J; Jeannot E
    Front Public Health; 2023; 11():1226779. PubMed ID: 37841741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
    Desta M; Getaneh T; Yeserah B; Worku Y; Eshete T; Birhanu MY; Kassa GM; Adane F; Yeshitila YG
    PLoS One; 2021; 16(11):e0259339. PubMed ID: 34735507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review.
    Devarapalli P; Labani S; Nagarjuna N; Panchal P; Asthana S
    Indian J Cancer; 2018; 55(4):318-326. PubMed ID: 30829264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening utilization, and associated factors, in Nepal: a systematic review and meta-analysis.
    Shrestha AD; Andersen JG; Gyawali B; Shrestha A; Shrestha S; Neupane D; Ghimire S; Campbell C; Kallestrup P
    Public Health; 2022 Sep; 210():16-25. PubMed ID: 35863158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "My motivation was to save": a qualitative study exploring factors influencing motivation of community healthcare workers in a cervical cancer screening program in Dschang, Cameroon.
    Hämmerli P; Moukam AD; Wisniak A; Sormani J; Vassilakos P; Kenfack B; Petignat P; Schmidt NC
    Reprod Health; 2022 Jun; 19(1):133. PubMed ID: 35668427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review.
    Bolarinwa OA; Holt N
    BMC Health Serv Res; 2023 Apr; 23(1):390. PubMed ID: 37087506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Health IT for Cancer Screening in US Primary Care: Scoping Review.
    Owens-Jasey C; Chen J; Xu R; Angier H; Huebschmann AG; Ito Fukunaga M; Chaiyachati KH; Rendle KA; Robien K; DiMartino L; Amante DJ; Faro JM; Kepper MM; Ramsey AT; Bressman E; Gold R
    JMIR Cancer; 2024 Apr; 10():e49002. PubMed ID: 38687595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
    Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
    Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon.
    Donatus L; Nina FK; Sama DJ; Nkfusai CN; Bede F; Shirinde J; Cumber SN
    Pan Afr Med J; 2019; 33():106. PubMed ID: 31489084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: a scoping review protocol.
    Kassa RN; Shifti DM; Alemu K; Omigbodun AO
    BMJ Open; 2024 Jan; 14(1):e078466. PubMed ID: 38191250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: a scoping review.
    Robbers GML; Bennett LR; Spagnoletti BRM; Wilopo SA
    Glob Health Action; 2021 Jan; 14(1):1979280. PubMed ID: 34586032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
    Roux AN; Kenfack B; Ndjalla A; Sormani J; Wisniak A; Tatrai K; Vassilakos P; Petignat P; Schmidt N
    BMJ Open; 2021 Jun; 11(6):e043637. PubMed ID: 34140340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.